These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27104)

  • 21. Platelet MAO concentration and molecular activity: II. Comparison of normal and schizophrenic populations.
    Rose RM; Castellani S; Boeringa JA; Malek-Ahmadi P; Lankford DA; Bessman JD; Fritz RR; Denney CB; Denney RM; Abell CW
    Psychiatry Res; 1986 Feb; 17(2):141-51. PubMed ID: 2870529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delusional misidentification and platelet monoamine oxidase.
    Barton JL; Chaparala S; Barton ES; Jackson IV; Davis LG
    Biol Psychiatry; 1980 Apr; 15(2):275-82. PubMed ID: 7417616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schizophrenia and platelet monoamine oxidase: research strategies.
    Buchsbaum MS; Coursey RD; Murphy DL
    Schizophr Bull; 1980; 6(2):375-84. PubMed ID: 6103578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased blood platelet MAO activity in unmedicated chronic schizophrenic patients.
    Domino EF; Khanna SS
    Am J Psychiatry; 1976 Mar; 133(3):323-6. PubMed ID: 943955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of nomifensine on platelet monoamine oxidase activity in chronic schizophrenic patients.
    Filinger EJ
    Gen Pharmacol; 1989; 20(6):821-2. PubMed ID: 2591711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet monoamine oxidase activity in schizophrenia.
    White HL; McLeod MN; Davidson JR
    Am J Psychiatry; 1976 Oct; 133(10):1191-3. PubMed ID: 970490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting determination of platelet monoamine oxidase activity.
    Jackman HL; Meltzer HY
    Schizophr Bull; 1980; 6(2):259-66. PubMed ID: 6103575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet monoamine oxidase response to lithium treatment in psychiatric patients.
    Huang LG; Bowden CL
    J Clin Psychopharmacol; 1984 Dec; 4(6):326-31. PubMed ID: 6512000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma levels of phenylacetic acid, m- and p-hydroxyphenylacetic acid, and platelet monoamine oxidase activity in schizophrenic and other patients.
    Davis BA; Yu PH; Carlson K; O'Sullivan K; Boulton AA
    Psychiatry Res; 1982 Feb; 6(1):97-105. PubMed ID: 6120530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The study of the platelet monoamine oxidase activity in chronic schizophrenic patients (author's transl)].
    Shohmori T; Kaneyuki T; Doi T; Mitani K; Kohsaka M
    Seishin Shinkeigaku Zasshi; 1977 Oct; 79(10):563-7. PubMed ID: 607254
    [No Abstract]   [Full Text] [Related]  

  • 31. Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity.
    Sullivan JL; Coffey CE; Basuk B; Cavenar JO; Maltbie AA; Zung WW
    Biol Psychiatry; 1980 Feb; 15(1):113-20. PubMed ID: 7357050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet monoamine oxidase activity in first-degree relatives of schizophrenic patients.
    Propping P; Friedl W
    Psychopharmacology (Berl); 1979 Nov; 65(3):265-72. PubMed ID: 117498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet monoamine oxidase activity in patients with chronic schizophrenic illnesses untreated by neuroleptic drugs [proceedings].
    Bailey AR; Crow TJ; Johnstone EC; Owen F
    Br J Clin Pharmacol; 1975 Aug; 2(4):380P. PubMed ID: 1234010
    [No Abstract]   [Full Text] [Related]  

  • 34. Platelet monoamine oxidase as a function of nongenetic factors.
    Friedhoff AJ; Miller JC
    Schizophr Bull; 1980; 6(2):314-9. PubMed ID: 6103576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipsychotic and MAO activities.
    Becker RE
    Am J Psychiatry; 1983 Jul; 140(7):955-7. PubMed ID: 6134476
    [No Abstract]   [Full Text] [Related]  

  • 36. Monoamine oxidase in schizophrenia: an overview.
    Wyatt RJ; Potkin SG; Bridge TP; Phelps BH; Wise CD
    Schizophr Bull; 1980; 6(2):199-207. PubMed ID: 7375851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet monoamine oxidase: studies on the rate of heat inactivation in normal and in paranoid and nonparanoid chronic schizophrenic groups.
    Wise CD; Bridge TP; Potkin SG; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):187-90. PubMed ID: 298348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients.
    Meltzer HY; Stahl SM
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):419-31. PubMed ID: 4594367
    [No Abstract]   [Full Text] [Related]  

  • 39. Some kinetic parameters of platelet monoamine oxidase in chronic schizophrenia.
    Kobes RD; Potkin SG; Wise CD; Bridge TP; Neckers LM; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):179-85. PubMed ID: 298347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet monamine oxidase in schizophrenia. An investigation in drug-free chronic hospitalized patients.
    Owen F; Bourne R; Crow TJ; Johnstone EC; Bailey AR; Hershon HI
    Arch Gen Psychiatry; 1976 Nov; 33(11):1370-3. PubMed ID: 791182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.